Actinomycin D upregulates proapoptotic protein Puma and downregulates Bcl-2 mRNA in normal peripheral blood lymphocytes
Language English Country England, Great Britain Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
17581298
DOI
10.1097/cad.0b013e3280adc905
PII: 00001813-200708000-00003
Knihovny.cz E-resources
- MeSH
- Apoptosis drug effects MeSH
- Dactinomycin administration & dosage pharmacology MeSH
- Down-Regulation MeSH
- Humans MeSH
- Lymphocytes drug effects MeSH
- RNA, Messenger metabolism MeSH
- Mitochondria metabolism MeSH
- Tumor Suppressor Protein p53 metabolism MeSH
- Reverse Transcriptase Polymerase Chain Reaction MeSH
- DNA Damage drug effects MeSH
- Apoptosis Regulatory Proteins metabolism MeSH
- Antibiotics, Antineoplastic administration & dosage pharmacology MeSH
- Proto-Oncogene Proteins c-bcl-2 metabolism MeSH
- Proto-Oncogene Proteins metabolism MeSH
- Flow Cytometry MeSH
- DNA, Ribosomal drug effects MeSH
- Up-Regulation drug effects MeSH
- Cell Survival MeSH
- Dose-Response Relationship, Drug MeSH
- Blotting, Western MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- BBC3 protein, human MeSH Browser
- Dactinomycin MeSH
- RNA, Messenger MeSH
- Tumor Suppressor Protein p53 MeSH
- Apoptosis Regulatory Proteins MeSH
- Antibiotics, Antineoplastic MeSH
- Proto-Oncogene Proteins c-bcl-2 MeSH
- Proto-Oncogene Proteins MeSH
- DNA, Ribosomal MeSH
We have examined the ability of actinomycin D to induce apoptosis in human peripheral blood lymphocytes. Run-On assays were performed to specify the primary molecular damage, reverse transcription-PCR, Western blots and flow cytometry studies were performed to ascertain which proteins of the apoptosis machinery were affected to cause actinomycin D-induced cell death. Expression of 23 apoptosis-related genes was investigated. The down-regulation of ribosomal RNA synthesis caused by actinomycin D induced a mitochondria-dependent apoptosis. Although the expression of the majority of examined genes remained indifferent against actinomycin D activity, the cellular level of p53 protein increased, subsequently upregulating both Puma mRNA and protein. Puma-mediated mitochondrial apoptosis was accompanied by nucleolin cleavage and Bcl-2 mRNA destabilization. The stability of the cellular level of Bcl-2 protein independent of a mRNA decrease suggests that protection of Bcl-2 protein against proteasomal degradation can moderate the apoptotic process. In peripheral blood lymphocytes cultured in vitro, the apoptosis induced by a low concentration of actinomycin D (10 nmol/l) is dependent on p53 and Puma activation. This apoptotic pathway is demonstrated in peripheral blood lymphocytes for the first time. A different apoptotic pathway induced in peripheral blood lymphocytes using this drug has, however, been previously revealed by other authors. The combination of cell specificity and dose-dependent effects can likely play a decisive role in apoptosis observed in peripheral blood lymphocytes after genotoxic drug application.
References provided by Crossref.org